You are here

• Home
• Therapy Areas
• Gastrointestinal

• A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40 mg qd and 20 mg qd) versus Ranitidine 150 mg bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued

Disease

gastrointestinal diseases

Drug Name

Nexium

Generic Name

esomeprazole

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

IIIa

Start Date

Feb 21, 2001

Study Name

SH-NEN-0006

Study Id

SH-NEN-0006

ClinicalTrials.gov ID

NCT00633672

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jan 18, 1971

• SH-NEN-0006.pdf (43 KB)

Page tools

• Print
• Bookmark this page